Clinical Trials Directory

Trials / Unknown

UnknownNCT05149547

mNGS Versus Blood Culture in FN

The Comparison of mNGS Versus Blood Culture for Early Diagnosis of Blood Stream Infection During the Febrile Neutropenia in Patients With Hematological Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers

Summary

Blood stream infection (BSI) during febrile neutropenia (FN) is a lethal complication, while confirmed diagnosis via blood culture is usually with low sensitivity and time delay. The new technique of metagenome next generation sequencing (mNGS) has the potential of early and more accurate detection of pathogens. However, this technique has not been well validated for BSI diagnosis in patients with hematological disease. Therefore, we designed a prospective multicenter study to compare the diagnosis performance in BSI.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTblood culture versus mNGS detectionperipheral 4ml for mNGS detection

Timeline

Start date
2021-10-15
Primary completion
2022-05-31
Completion
2022-08-31
First posted
2021-12-08
Last updated
2021-12-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05149547. Inclusion in this directory is not an endorsement.